Among these parameters, dP/dt of the pulmonary artery was found to be the most accurate predictor of the probability of improvement in the 6-MWT and the NT-proBNP levels following initiation of a specific medication for PAH. The gene discussed is NPPB; the disease is pulmonary arterial hypertension.